Niklas Carln - Stille AB CFO Board
| STIL Stock | SEK 203.00 4.00 1.93% |
Insider
Niklas Carln is CFO Board of Stille AB
| Age | 49 |
| Phone | 46 8 58 85 80 00 |
| Web | https://www.stille.se |
Stille AB Management Efficiency
The company has return on total asset (ROA) of 0.0588 % which means that it generated a profit of $0.0588 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1601 %, meaning that it generated $0.1601 on every $100 dollars invested by stockholders. Stille AB's management efficiency ratios could be used to measure how well Stille AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Johan Holmstrom | Xvivo Perfusion AB | 53 | |
| Lotta Bus | BICO Group AB | 53 | |
| Henrik Ljung | SpectraCure AB | 65 | |
| Slavoljub Grujicic | Senzime AB | 53 | |
| Johan Folkunger | SpectraCure AB | 55 | |
| Kristina Holst | SpectraCure AB | N/A | |
| Johanna Tulkki | Senzime AB | 53 | |
| Artur Aira | BICO Group AB | 56 | |
| Mikael Engblom | BICO Group AB | 46 | |
| Gran Malmberg | Mentice AB | 64 | |
| Lena BSc | Xvivo Perfusion AB | 58 | |
| Karin Danielsson | BICO Group AB | 41 | |
| Benjamin Speich | Mentice AB | 41 | |
| Jason Clifton | BICO Group AB | N/A | |
| Pontus Appelqvist | Mentice AB | N/A | |
| Charlotte Walldal | Xvivo Perfusion AB | 56 | |
| Johannes Swartling | SpectraCure AB | 51 | |
| Anders Selin | Senzime AB | 61 | |
| Katrin Gisselfalt | Xvivo Perfusion AB | 54 | |
| Stacy Hammar | Mentice AB | N/A | |
| Andreas MD | Xvivo Perfusion AB | 46 | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0588 |
Stille AB Management Team
Elected by the shareholders, the Stille AB's board of directors comprises two types of representatives: Stille AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stille. The board's role is to monitor Stille AB's management team and ensure that shareholders' interests are well served. Stille AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stille AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Niklas Carln, CFO Board | ||
| John Anderson, Head Devel | ||
| Hanna Wilkman, MD CEO |
Stille Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stille AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0588 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 667.84 M | |||
| Shares Outstanding | 5.01 M | |||
| Shares Owned By Insiders | 46.70 % | |||
| Shares Owned By Institutions | 39.07 % | |||
| Price To Earning | 19.85 X | |||
| Price To Book | 3.37 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stille Stock Analysis
When running Stille AB's price analysis, check to measure Stille AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stille AB is operating at the current time. Most of Stille AB's value examination focuses on studying past and present price action to predict the probability of Stille AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stille AB's price. Additionally, you may evaluate how the addition of Stille AB to your portfolios can decrease your overall portfolio volatility.